| Title | Efficacy, safety and potential mechanisms of Olverembatinib in advanced succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST): results from a phase 1b study and translational research |
|---|---|
| Description | Efficacy, safety and potential mechanisms of Olverembatinib in advanced succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST): results from a phase 1b study and translational research |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA026539 |
| Release Date | 2025-12-03 |
| Submitter | Yifan Zhai (yzhai@ascentage.com) |
| Organization | Ascentage Pharma (Suzhou) Co., Ltd |
| Submission Date | 2025-08-06 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX011352-01 | The Genomics Date Chart of Manuscript | 1 | Other Type of Genomic Data | 776.0 KB | Unavailable | |
| OMIX011352-02 | The Genomics Date Chart of Supplementary Information | 1 | Other Type of Genomic Data | 371.6 KB | Unavailable |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|---|---|---|---|
| Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational research | Signal Transduction and Targeted Therapy | 2025-11 | OMIX015800 OMIX011595 OMIX011594 OMIX011593 OMIX011592 OMIX011431 OMIX011424 OMIX011422 OMIX011352 OMIX010350 OMIX010183 OMIX010075 OMIX006519 | Deposit |